Jubilant Company Profile
What is the competitive landscape for JUBILANT
JUBILANT has ninety approved drugs.
Summary for Jubilant
| US Patents: | 0 |
| Tradenames: | 80 |
| Ingredients: | 76 |
| NDAs: | 90 |
| Patent Litigation for Jubilant: | See patent lawsuits for Jubilant |
Drugs and US Patents for Jubilant
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jubilant Cadista | LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 201170-001 | Sep 18, 2012 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Jubilant Generics | CELECOXIB | celecoxib | CAPSULE;ORAL | 207061-003 | Apr 4, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Jubilant Cadista | TERAZOSIN HYDROCHLORIDE | terazosin hydrochloride | CAPSULE;ORAL | 075317-001 | Dec 20, 2004 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
